1. Home
  2. FWRD vs DCTH Comparison

FWRD vs DCTH Comparison

Compare FWRD & DCTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Forward Air Corporation

FWRD

Forward Air Corporation

HOLD

Current Price

$8.70

Market Cap

339.4M

ML Signal

HOLD

Logo Delcath Systems Inc.

DCTH

Delcath Systems Inc.

HOLD

Current Price

$11.11

Market Cap

363.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FWRD
DCTH
Founded
1981
1988
Country
United States
United States
Employees
N/A
N/A
Industry
Oil Refining/Marketing
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
339.4M
363.5M
IPO Year
2024
2015

Fundamental Metrics

Financial Performance
Metric
FWRD
DCTH
Price
$8.70
$11.11
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
4
Target Price
$37.50
$22.00
AVG Volume (30 Days)
1.5M
378.1K
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
88.54
107.53
EPS
N/A
N/A
Revenue
$1,269,573,000.00
N/A
Revenue This Year
$6.57
$24.54
Revenue Next Year
$6.66
$33.15
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$8.65
$8.12
52 Week High
$32.47
$18.23

Technical Indicators

Market Signals
Indicator
FWRD
DCTH
Relative Strength Index (RSI) 25.27 53.27
Support Level N/A $10.17
Resistance Level $30.86 $11.24
Average True Range (ATR) 1.49 0.56
MACD -1.22 -0.02
Stochastic Oscillator 1.04 46.85

Price Performance

Historical Comparison
FWRD
DCTH

About FWRD Forward Air Corporation

Forward Air Corp is an asset-light freight and logistics company. The company's operating segment includes Expedited Freight, Omni Logistics, and Intermodal and Corporate. The company generates maximum revenue from the Omni Logistics segment. The expedited Freight segment operates a comprehensive national network to provide expedited regional, inter-regional, and national LTL (less-than-truckload) services. It also offers customers local pick-up and delivery and other services including final mile, truckload, shipment consolidation and deconsolidation, warehousing, customs brokerage, and other handling. The Company conducts business in North and South America, Europe, and Asia.

About DCTH Delcath Systems Inc.

Delcath Systems Inc is an oncology company. The company is focused on the treatment of primary and metastatic liver cancers. The firm's product include Melphalan Hydrochloride, Hepzato for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.

Share on Social Networks: